Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation

[1]  E. Kandel,et al.  Nitric oxide and carbon monoxide produce activity-dependent long-term synaptic enhancement in hippocampus. , 1993, Science.

[2]  M. V. Hogan,et al.  Long-term potentiation in the hippocampus induced by platelet-activating factor , 1993, Neuron.

[3]  D. Clifford,et al.  Long-term potentiation during whole-cell recording in rat hippocampal slices , 1993, Neuroscience.

[4]  C. Zorumski,et al.  Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor , 1992, Neuron.

[5]  E. Kandel,et al.  Are adult learning mechanisms also used for development? , 1992, Science.

[6]  D. Clifford,et al.  Inhibition of long-term potentiation by NMDA-mediated nitric oxide release. , 1992, Science.

[7]  V. Gribkoff,et al.  Evidence for nitric oxide synthase inhibitor-sensitive and insensitive hippocampal synaptic potentiation. , 1992, Journal of neurophysiology.

[8]  A. Ogura,et al.  Platelet-activating factor (PAF) receptor in rat brain: PAF mobilizes intracellular Ca2+ in hippocampal neurons , 1992, Neuron.

[9]  H. Lal,et al.  Emerging Strategies in Neuroprotection , 1992 .

[10]  G. Lynch,et al.  Antagonists of the Platelet‐activating Factor Receptor Block Long‐term Potentiation in Hippocampal Slices , 1992, The European journal of neuroscience.

[11]  D. Attwell,et al.  Potentiation of NMDA receptor currents by arachidonic acid , 1992, Nature.

[12]  R. Nicoll,et al.  Postsynaptic contribution to long-term potentiation revealed by the analysis of miniature synaptic currents , 1992, Nature.

[13]  E. Kandel,et al.  Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Madison,et al.  A requirement for the intercellular messenger nitric oxide in long-term potentiation. , 1991, Science.

[15]  Hiroshi Kato,et al.  Both arachidonic acid and 1-oleoyl-2-acetyl glycerol in low magensium solution induce long-term potentiation in hippocampal CA1 neurons in vitro , 1991, Brain Research.

[16]  S. Snyder,et al.  Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase , 1991, Neuron.

[17]  G. Zimmerman,et al.  Platelet-activating Factor , 1991 .

[18]  M. Lynch,et al.  Presynaptic Changes in Long‐Term Potentiation: Elevated Synaptosomal Calcium Concentration and Basal Phosphoinositide Turnover in Dentate Gyrus , 1991, Journal of neurochemistry.

[19]  E. Kumamoto,et al.  Long-term potentiations in vertebrate synapses: a variety of cascades with common subprocesses , 1990, Progress in Neurobiology.

[20]  G. Lynch,et al.  Inhibition of long-term potentiation by an antagonist of platelet-activating factor receptors. , 1990, Behavioral and neural biology.

[21]  C. Stevens,et al.  Presynaptic mechanism for long-term potentiation in the hippocampus , 1990, Nature.

[22]  P. Braquet,et al.  Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex. , 1990, The Journal of biological chemistry.

[23]  T. Yue,et al.  Production of Platelet‐Activating Factor from Rat Cerebellar Granule Cells in Culture , 1990, Journal of neurochemistry.

[24]  T. Bliss,et al.  Nordihydroguaiaretic acid blocks the synaptic component of long-term potentiation and the associated increases in release of glutamate and arachidonate: An in vivo study in the dentate gyrus of the rat , 1989, Neuroscience.

[25]  T. Bliss,et al.  Arachidonic acid induces a long-term activity-dependent enhancement of synaptic transmission in the hippocampus , 1989, Nature.

[26]  N. Bazan.  Arachidonic Acid in the Modulation of Excitable Membrane Function and at the Onset of Brain Damage a , 1989, Annals of the New York Academy of Sciences.

[27]  N. Bazan,et al.  Membrane-Derived Lipid Second Messengers as Targets for Neuroprotection: Platelet-Activating Factor , 1992 .